HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 365Generated: October 28, 2026
2,4-Dichloropyridine → N-(4-chloro-2-pyridinyl)-1,3-oxazol-2-amine
https://huagongshe.com/reaction/365
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 2,4-Dichloropyridine | HCID 33515 | — |
| Reactant | 2-Aminooxazole | HCID 558521 | — |
| Reagent | Cesium carbonate | HCID 10796 | — |
| Catalyst | 1,1'-(9,9-Dimethyl-9H-xanthene-4,5-diyl)bis(1,1-diphenylphosphine) | HCID 636044 | — |
| Catalyst | Palladium (II) acetate | HCID 4144353 | — |
| Solvent | Dimethylacetamide | HCID 31374 | — |
| Product | N-(4-chloro-2-pyridinyl)-1,3-oxazol-2-amine | HCID 130016260 | 1.97% |
Reaction Steps
oxazol-2-amine (85 mg, 1.01 mmol), 2,4-dichloropyridine (0.151 mL, 1.01 mmol), 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene (70.4 mg, 0.12 mmol) and cesium carbonate (660 mg, 2.03 mmol) were stirred in DMA (5 mL). The mixture was purged with nitrogen for 10 minutes. Palladium(II) acetate (22.76 mg, 0.10 mmol) was added and the mixture heated at 100 °C for 70h. The mixture was cooled, filtered and concentrated. The crude product was purified by preparative HPLC (Waters XBridge Prep C18 OBD column, 5µ silica, 19 mm diameter, 100 mm length), using decreasingly polar mixtures of water (containing 1% NH3) and MeCN as eluents. Fractions containing the desired compound were evaporated to dryness to afford N-(4-chloropyridin-2-yl)oxazol-2-amine (3.90 mg, 1.967 %).
Provenance & Evidence
| Source dataset | 750 AstraZeneca ELN dataset |
|---|
| ORD ID | ord-1cd8c235ce4f4167a93c6067f176b339 |
|---|
| Source note | 750 AstraZeneca ELN dataset |
|---|